Potential risk factors include: Previous allergic reactions to GLP-1 receptor agonists (such as liraglutide, dulaglutide, or exenatide) History of drug allergies , particularly to injectable medications Multiple drug allergies or documented hypersensitivity to various medications Before prescribing Wegovy, healthcare professionals should conduct a comprehensive allergy assessment in line with NICE Clinical Guideline 183 (Drug Allergy)
Funding Statement These authors have no support or funding to report
Tirzepatide, acting on both GIP and GLP-1 receptors, is effective in reducing weight and controlling glucose, providing superior weight loss effects
This result, known as Jensen's inequality, can be used to deduce inequalities such as the arithmeticgeometric mean inequality and Hlder's inequality
Maintenance: Sexual effects persist but are less intense with lower dosing frequency